Ambrx Biopharma Inc. Shareholder Equity
- 2023-06-30: Common Stock, Value, IssuedUSD $43.00K; Additional Paid in CapitalUSD $576.05M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-953.00K; Retained Earnings (Accumulated Deficit)USD $-324.76M.
- 2023-03-31: Common Stock, Value, IssuedUSD $39.00K; Additional Paid in CapitalUSD $490.46M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-976.00K; Retained Earnings (Accumulated Deficit)USD $-306.93M.
- 2022-12-31: Common Stock, Value, IssuedUSD $27.00K; Additional Paid in CapitalUSD $410.75M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.30M; Retained Earnings (Accumulated Deficit)USD $-291.63M.
- 2022-06-30: Common Stock, Value, IssuedUSD $27.00K; Additional Paid in CapitalUSD $407.99M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.01M; Retained Earnings (Accumulated Deficit)USD $-265.12M.
Ambrx Biopharma Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $43.00K | $576.05M | $-953.00K | $-324.76M | $250.38M | 3 month · $2.10M 6 month · $4.03M | (m) | 3 month · $-36.00K 6 month · $-388.00K |
| 2023-03-31 | $39.00K | $490.46M | $-976.00K | $-306.93M | $182.59M | 3 month · $1.94M | (m) | 3 month · $-352.00K |
| 2022-12-31 | $27.00K | $410.75M | $-1.30M | $-291.63M | $117.85M | 12 month · $6.25M | (m) | (m) |
| 2022-06-30 | $27.00K | $407.99M | $-1.01M | $-265.12M | $141.89M | 3 month · $1.88M 6 month · $3.53M | (m) | 3 month · $0.00 6 month · $0.00 |
| 2022-03-31 | (m) | (m) | (m) | (m) | $168.98M | 3 month · $1.65M | (m) | 3 month · $0.00 |
| 2021-12-31 | $27.00K | $404.36M | $-790.00K | $-213.63M | $189.97M | 12 month · $11.86M | 12 month · $26.34M | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | $192.80M | 6 month · $8.96M | 6 month · $26.34M | (m) |
| 2020-12-31 | $0.00 | $6.80M | $-686.00K | $-145.55M | $-139.43M | 12 month · $1.22M | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $33.42M | 12 month · $1.83M | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $51.69M | (m) | (m) | (m) |